{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:08:27Z","timestamp":1782310107455,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28967-7","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T18:03:33Z","timestamp":1763921013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the correlation between patient and family reported outcome measures and multiple myeloma clinical parameters"],"prefix":"10.1038","volume":"15","author":[{"given":"Mouna","family":"Ballan-Haj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Midlej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Draliuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mishchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Valkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshan","family":"Perek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Warwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem","family":"Zoabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Preis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"28967_CR1","doi-asserted-by":"publisher","first-page":"e1406","DOI":"10.1634\/theoncologist.2020-0141","volume":"25","author":"H Ludwig","year":"2020","unstructured":"Ludwig, H., Novis Durie, S., Meckl, A., Hinke, A. & Durie, B. Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment. Oncologist 25, e1406\u2013e1413 (2020).","journal-title":"Oncologist"},{"key":"28967_CR2","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"28967_CR3","doi-asserted-by":"crossref","unstructured":"Kyle, R. A. et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin. Proc. 78, 21\u201333 (2003).","DOI":"10.4065\/78.1.21"},{"key":"28967_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1158\/0008-5472.CAN-07-3096","volume":"68","author":"W Matsui","year":"2008","unstructured":"Matsui, W. et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res. 68, 190\u2013197 (2008).","journal-title":"Cancer Res."},{"key":"28967_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.soncn.2017.05.012","volume":"33","author":"K Brigle","year":"2017","unstructured":"Brigle, K. & Rogers, B. Pathobiology and diagnosis of multiple myeloma. Semin Oncol. Nurs. 33, 225\u2013236 (2017).","journal-title":"Semin Oncol. Nurs."},{"key":"28967_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/sj.bmt.1705395","volume":"38","author":"NJ Bahlis","year":"2006","unstructured":"Bahlis, N. J. & Lazarus, H. M. Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted? Bone Marrow Transpl. 38, 7\u201315 (2006).","journal-title":"Bone Marrow Transpl."},{"key":"28967_CR7","first-page":"373","volume":"95","author":"TC Michels","year":"2017","unstructured":"Michels, T. C. & Petersen, K. E. Multiple myeloma: diagnosis and treatment. Am. Fam Physician. 95, 373\u2013383 (2017).","journal-title":"Am. Fam Physician"},{"key":"28967_CR8","unstructured":"Multiple myeloma. Clinical features, Laboratory manifestations, and Diagnosis. https:\/\/www.uptodate.com\/contents\/multiple-myeloma-clinical-features-laboratory-manifestations-and-diagnosis?search=multiple%20myeloma&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. 2025"},{"key":"28967_CR9","doi-asserted-by":"publisher","first-page":"1032775","DOI":"10.3389\/fonc.2022.1032775","volume":"12","author":"SF Cho","year":"2022","unstructured":"Cho, S. F., Yeh, T. J., Anderson, K. C. & Tai, Y. T. Bispecific antibodies in multiple myeloma treatment: a journey in progress. Front. Oncol. 12, 1032775 (2022).","journal-title":"Front. Oncol."},{"key":"28967_CR10","unstructured":"IMWG Uniform Response Criteria | Int\u2019l Myeloma Fn. https:\/\/www.myeloma.org\/resource-library\/international-myeloma-working-group-imwg-uniform-response-criteria-multiple"},{"key":"28967_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1600-0609.2012.01831.x","volume":"89","author":"F Mols","year":"2012","unstructured":"Mols, F. et al. Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 year after diagnosis: results from a population-based study using the PROFILES registry. Eur. J. Haematol. 89, 311\u2013319 (2012).","journal-title":"Eur. J. Haematol."},{"key":"28967_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1046\/j.0902-4441.2003.00195.x","volume":"72","author":"N Gulbrandsen","year":"2004","unstructured":"Gulbrandsen, N., Hjermstad, M. J., Wisl\u00f8ff, F. & Nordic Myeloma Study Group. Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. Eur. J. Haematol. 72, 172\u2013180 (2004).","journal-title":"Eur. J. Haematol."},{"key":"28967_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1600-0609.2009.01250.x","volume":"83","author":"AT Johnsen","year":"2009","unstructured":"Johnsen, A. T., Tholstrup, D., Petersen, M. A., Pedersen, L. & Groenvold, M. Health related quality of life in a nationally representative sample of haematological patients. Eur. J. Haematol. 83, 139\u2013148 (2009).","journal-title":"Eur. J. Haematol."},{"key":"28967_CR14","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/(SICI)1097-0142(19980415)82:8<1501::AID-CNCR11>3.0.CO;2-8","volume":"82","author":"SV Rajkumar","year":"1998","unstructured":"Rajkumar, S. V., Gertz, M. A. & Kyle, R. A. Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer 82, 1501\u20131505 (1998).","journal-title":"Cancer"},{"key":"28967_CR15","doi-asserted-by":"crossref","unstructured":"R\u00edos-Tamayo, R. et al. AL amyloidosis and multiple myeloma: A complex scenario in which cardiac involvement remains the key prognostic factor. Life (Basel) 13, 1-11 (2023).","DOI":"10.3390\/life13071518"},{"key":"28967_CR16","unstructured":"Overview of amyloidosis. https:\/\/www.uptodate.com\/contents\/overview-of-amyloidosis?search=amyloidosis%20&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H10."},{"key":"28967_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/1471-2407-14-496","volume":"14","author":"TR Osborne","year":"2014","unstructured":"Osborne, T. R. et al. Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of life. BMC Cancer. 14, 496 (2014).","journal-title":"BMC Cancer"},{"key":"28967_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40271-023-00616-z","volume":"16","author":"C Bennink","year":"2023","unstructured":"Bennink, C. et al. Improving Outcome-Driven care in multiple myeloma using Patient-Reported outcomes: A qualitative evaluation study. Patient 16, 255\u2013264 (2023).","journal-title":"Patient"},{"key":"28967_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11136-013-0457-y","volume":"23","author":"CJ Golics","year":"2014","unstructured":"Golics, C. J., Basra, M. K. A., Finlay, A. Y. & Salek, S. The development and validation of the family reported outcome measure (FROM-16)\u00a9 to assess the impact of disease on the partner or family member. Qual. Life Res. 23, 317\u2013326 (2014).","journal-title":"Qual. Life Res."},{"key":"28967_CR20","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/pon.3552","volume":"23","author":"AC Wootten","year":"2014","unstructured":"Wootten, A. C. et al. The impact of prostate cancer on partners: a qualitative exploration. Psychooncology 23, 1252\u20131258 (2014).","journal-title":"Psychooncology"},{"key":"28967_CR21","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1002\/1097-0142(19940601)73:11<2791::AID-CNCR2820731123>3.0.CO;2-9","volume":"73","author":"AB Kornblith","year":"1994","unstructured":"Kornblith, A. B., Herr, H. W., Ofman, U. S., Scher, H. I. & Holland, J. C. Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer 73, 2791\u20132802 (1994).","journal-title":"Cancer"},{"key":"28967_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1352\/0047-6765(2003)41<313:FQOLAQ>2.0.CO;2","volume":"41","author":"D Poston","year":"2003","unstructured":"Poston, D. et al. Family quality of life: a qualitative inquiry. Ment Retard. 41, 313\u2013328 (2003).","journal-title":"Ment Retard."},{"key":"28967_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12955-021-01819-4","volume":"19","author":"R Shah","year":"2021","unstructured":"Shah, R., Ali, F. M., Finlay, A. Y. & Salek, M. S. Family reported outcomes, an unmet need in the management of a patient\u2019s disease: appraisal of the literature. Health Qual. Life Outcomes. 19, 194 (2021).","journal-title":"Health Qual. Life Outcomes"},{"key":"28967_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson, M. E., Carrozzino, D., Guidi, J. & Patierno, C. Charlson comorbidity index: a critical review of clinimetric properties. Psychother. Psychosom. 91, 8\u201335 (2022).","journal-title":"Psychother. Psychosom."},{"key":"28967_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40, 373\u2013383 (1987).","journal-title":"J. Chronic Dis."},{"key":"28967_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson, M., Szatrowski, T. P., Peterson, J. & Gold, J. Validation of a combined comorbidity index. J. Clin. Epidemiol. 47, 1245\u20131251 (1994).","journal-title":"J. Clin. Epidemiol."},{"key":"28967_CR27","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.ejca.2007.04.022","volume":"43","author":"K Cocks","year":"2007","unstructured":"Cocks, K. et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur. J. Cancer. 43, 1670\u20131678 (2007).","journal-title":"Eur. J. Cancer"},{"key":"28967_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/ejh.12012","volume":"89","author":"TR Osborne","year":"2012","unstructured":"Osborne, T. R. et al. What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools. Eur. J. Haematol. 89, 437\u2013457 (2012).","journal-title":"Eur. J. Haematol."},{"key":"28967_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1046\/j.1365-2141.1996.352889.x","volume":"92","author":"F Wisl\u00f8ff","year":"1996","unstructured":"Wisl\u00f8ff, F. et al. Measurement of health-related quality of life in multiple myeloma. Br. J. Haematol. 92, 604\u2013613 (1996).","journal-title":"Br. J. Haematol."},{"key":"28967_CR30","unstructured":"FAQ Categories. Scoring | EORTC \u2013 Quality of Life: EORTC \u2013 Quality of Life. https:\/\/qol.eortc.org\/faq-category\/scoring\/"},{"key":"28967_CR31","unstructured":"Emotional. Scoring of the QLQ-C30 Summary Score."},{"key":"28967_CR32","unstructured":"QLQ-MY. EORTC QLQ - MY20 Scoring Manual. https:\/\/www.eortc.be\/qol\/ScoringInstructions\/MY20%20Summary.pdf"},{"key":"28967_CR33","unstructured":"IBMCorp. IBM SPSS Statistics for Windows, Version 25.0Armonk, NY (2017)."},{"key":"28967_CR34","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1200\/JCO.2005.04.0824","volume":"24","author":"D Dubois","year":"2006","unstructured":"Dubois, D. et al. Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma. J. Clin. Oncol. 24, 976\u2013982 (2006).","journal-title":"J. Clin. Oncol."},{"key":"28967_CR35","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/leu.2013.185","volume":"27","author":"P Sonneveld","year":"2013","unstructured":"Sonneveld, P. et al. Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia 27, 1959\u20131969 (2013).","journal-title":"Leukemia"},{"key":"28967_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/ejh.14206","volume":"113","author":"R Shah","year":"2024","unstructured":"Shah, R. et al. Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: a cross-sectional study. Eur. J. Haematol. 113, 117\u2013126 (2024).","journal-title":"Eur. J. Haematol."},{"key":"28967_CR37","doi-asserted-by":"crossref","unstructured":"Kvam, A. K. & Waage, A. Health-related quality of life in patients with multiple myeloma\u2013does it matter? Haematologica. 100, 704\u2013705 (2015).","DOI":"10.3324\/haematol.2015.127860"},{"key":"28967_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1586\/erp.11.9","volume":"11","author":"MT King","year":"2011","unstructured":"King, M. T. A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev. Pharmacoecon Outcomes Res. 11, 171\u2013184 (2011).","journal-title":"Expert Rev. Pharmacoecon Outcomes Res."},{"key":"28967_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s41687-024-00703-1","volume":"8","author":"R Shah","year":"2024","unstructured":"Shah, R. et al. Responsiveness and minimal important change of the family reported outcome measure (FROM-16). J. Patient Rep. Outcomes. 8, 38 (2024).","journal-title":"J. Patient Rep. Outcomes"},{"key":"28967_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-8-79","volume":"8","author":"AK Kvam","year":"2010","unstructured":"Kvam, A. K., Wisl\u00f8ff, F. & Fayers, P. M. Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma. Health Qual. Life Outcomes. 8, 79 (2010).","journal-title":"Health Qual. Life Outcomes"},{"key":"28967_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/1360786021000006947","volume":"6","author":"BH Gottlieb","year":"2002","unstructured":"Gottlieb, B. H. & Wolfe, J. Coping with family caregiving to persons with dementia: a critical review. Aging Ment Health. 6, 325\u2013342 (2002).","journal-title":"Aging Ment Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28967-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28967-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:05:26Z","timestamp":1777122326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28967-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28967"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28967-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conflicts of Interest: Andrew Yule Finlay is a joint copyright owner of FROM-16. Cardiff University gains royalties from its use. Andrew Yule Finlay receives a share of these under standard university policy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"According to current guidelines and following the Ethics Committee of the Carmel Medical Center, Haifa, Israel, the committee reviewed and approved this research project and study design with approval number 0083-19-CMC.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"45172"}}